Literature DB >> 25555157

Enhancement and wavelength-shifted emission of Cerenkov luminescence using multifunctional microspheres.

Joanne Li1, Lawrence W Dobrucki, Marina Marjanovic, Eric J Chaney, Kenneth S Suslick, Stephen A Boppart.   

Abstract

Cerenkov luminescence (CL) imaging is a new molecular imaging modality that utilizes the photons emitted during radioactive decay when charged particles travel faster than the phase velocity of light in a dielectric medium. Here we present a novel agent to convert and increase CL emission at longer wavelengths using multimodal protein microspheres (MSs). The (64)Cu-labeled protein microspheres contain quantum dots (QDs) encapsulated within a high-refractive-index-oil core. Dark box imaging of the MSs was conducted to demonstrate the improvement in CL emission at longer wavelengths. To illustrate the versatile design of these MSs and the potential of CL in disease diagnosis, these MSs were utilized for in vitro cell targeting and ex vivo CL-excited QD fluorescence (CL-FL) imaging of atherosclerotic plaques in rats. It was shown that by utilizing both QDs and MSs with a high-refractive-index-oil core, the CL emission increases by four-fold at longer wavelengths. Furthermore, we demonstrate that these MSs generate both an in vivo and ex vivo contrast signal. The design concept of utilizing QDs and high-index core MSs may contribute to future developments of in vivo CL imaging.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25555157      PMCID: PMC4310693          DOI: 10.1088/0031-9155/60/2/727

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  27 in total

1.  Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

Authors:  T Jackson; A Sharma; R A Ghazaleh; W E Blakemore; F M Ellard; D L Simmons; J W Newman; D I Stuart; A M King
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

3.  Clinical Cerenkov luminescence imaging of (18)F-FDG.

Authors:  Daniel L J Thorek; Christopher C Riedl; Jan Grimm
Journal:  J Nucl Med       Date:  2013-09-27       Impact factor: 10.057

4.  Cerenkov luminescence imaging of medical isotopes.

Authors:  Alessandro Ruggiero; Jason P Holland; Jason S Lewis; Jan Grimm
Journal:  J Nucl Med       Date:  2010-06-16       Impact factor: 10.057

Review 5.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

6.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

7.  Tumor targeting by surface-modified protein microspheres.

Authors:  Farah Jean-Jacques Toublan; Stephen Boppart; Kenneth S Suslick
Journal:  J Am Chem Soc       Date:  2006-03-22       Impact factor: 15.419

8.  Cerenkov radiation energy transfer (CRET) imaging: a novel method for optical imaging of PET isotopes in biological systems.

Authors:  Robin S Dothager; Reece J Goiffon; Erin Jackson; Scott Harpstrite; David Piwnica-Worms
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

9.  Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.

Authors:  Carmen Burtea; Sophie Laurent; Oltea Murariu; Dirk Rattat; Gérard Toubeau; Alfons Verbruggen; David Vansthertem; Luce Vander Elst; Robert N Muller
Journal:  Cardiovasc Res       Date:  2008-01-03       Impact factor: 10.787

10.  Alpha-v beta-3 integrin expression in normal and atherosclerotic artery.

Authors:  M Hoshiga; C E Alpers; L L Smith; C M Giachelli; S M Schwartz
Journal:  Circ Res       Date:  1995-12       Impact factor: 17.367

View more
  5 in total

Review 1.  Radionuclide-Activated Nanomaterials and Their Biomedical Applications.

Authors:  Carolina A Ferreira; Dalong Ni; Zachary T Rosenkrans; Weibo Cai
Journal:  Angew Chem Int Ed Engl       Date:  2019-07-08       Impact factor: 15.336

Review 2.  Utilizing the power of Cerenkov light with nanotechnology.

Authors:  Travis M Shaffer; Edwin C Pratt; Jan Grimm
Journal:  Nat Nanotechnol       Date:  2017-02-07       Impact factor: 39.213

Review 3.  Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.

Authors:  Shreya Goel; Christopher G England; Feng Chen; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2016-08-09       Impact factor: 15.470

Review 4.  Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences.

Authors:  Esther Ciarrocchi; Nicola Belcari
Journal:  EJNMMI Phys       Date:  2017-03-11

5.  Redshifted Cherenkov Radiation for in vivo Imaging: Coupling Cherenkov Radiation Energy Transfer to multiple Förster Resonance Energy Transfers.

Authors:  Yann Bernhard; Bertrand Collin; Richard A Decréau
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.